Puma Biotechnology (PBYI) Common Equity (2010 - 2026)
Puma Biotechnology (PBYI) posted Common Equity of $138.54 million for Q2 2026, up 32.3% from $104.72 million a year earlier and up 7.9% from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Puma Biotechnology's Common Equity came in at $130.34 million, up 41.5% from FY2024.
- Annual Common Equity has increased for three consecutive years.
- In prior years, Puma Biotechnology's Common Equity was $92.13 million in FY2024 (+72.4%), $53.44 million in FY2023 (+147.3%), $21.61 million in FY2022 and -$2.45 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q1 2017.
- On a year-over-year basis, Common Equity has increased in each of the last 14 quarters, with growth averaging 66.3% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2023, with growth of 261.7%; the weakest was Q1 2022, with a decline of 56.3%.
- According to Business Quant data, Common Equity for the three prior quarters was $128.42 million (Q1 2026), $130.34 million (Q4 2025) and $115.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 138.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 138.54 Mn |
| Mar 31, 2026 | 128.42 Mn |
| Dec 31, 2025 | 130.34 Mn |
| Sep 30, 2025 | 115.27 Mn |
| Jun 30, 2025 | 104.72 Mn |
| Mar 31, 2025 | 97.11 Mn |
| Dec 31, 2024 | 92.13 Mn |
| Sep 30, 2024 | 71.09 Mn |
| Jun 30, 2024 | 48.51 Mn |
| Mar 31, 2024 | 50.98 Mn |
| Dec 31, 2023 | 53.44 Mn |
| Sep 30, 2023 | 38.74 Mn |
| Jun 30, 2023 | 30.40 Mn |
| Mar 31, 2023 | 25.85 Mn |
| Dec 31, 2022 | 21.61 Mn |
| Sep 30, 2022 | 22.16 Mn |
| Jun 30, 2022 | 19.74 Mn |
| Mar 31, 2022 | 7.15 Mn |
| Dec 31, 2021 | -2.45 Mn |
| Sep 30, 2021 | -10.92 Mn |
API Access
Puma Biotechnology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();